Sol-Gel Technologies Ltd.'s SEC filings document the disclosure record of a foreign private issuer developing and partnering dermatology drug products. Form 6-K reports include operating and financial results, unaudited condensed financial statements, clinical and regulatory updates for SGT-610, SGT-210 and EPSOLAY, and material-event disclosures incorporated by reference into the company's Form S-8 and Form F-3 registration statements.
The filings also cover shareholder meeting materials, auditor appointments, board elections, interim executive leadership approvals under Israeli corporate governance requirements, and capital-structure matters involving the company's ordinary shares. These documents frame Sol-Gel's public-company reporting around dermatology pipeline development, approved topical products, licensing arrangements, governance actions, and financing capacity.
Sol-Gel Technologies Ltd. Chairman and CEO Moshe Arkin filed an initial ownership report showing his stake in the company. He reports indirect ownership of warrants giving the right to buy 200,000 ordinary shares at an exercise price of $58.50 per share, expiring on January 27, 2028, through M. Arkin Dermatology Ltd. He also reports 143,257 ordinary shares held directly and 1,606,856 ordinary shares held indirectly through M. Arkin Dermatology Ltd. A footnote states he disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
SLGL filed a Form 144 reporting proposed sales of Ordinary shares under an Employee Stock Option Plan, to be settled for cash upon exercise.
The excerpt lists two dispositions by Yosef Itzik during the past three months: 1,168 Ordinary shares on 01/07/2026 for $70,250.51 and 2,726 Ordinary shares on 02/23/2026 for $240,192.00. The filing references Nasdaq and Ordinary share class.
Form 144 filing reporting proposed sale of ordinary shares through Oppenheimer & Co. The filing lists 1,556 ordinary shares tied to an employee stock option plan with a broker of record of Oppenheimer & Co. Inc. and a broker date of 02/25/2026. The excerpt includes per-holder examples, including Yosef Itzik: 1,168 shares on 01/07/2026 and 1,170 shares on 02/23/2026, with associated dollar figures shown in the rows. Cash upon exercise is shown as the method for the plan.
Itzik Yosef filed a Form 144 to sell 1,170 ordinary shares of SLGL. The filing lists the proposed sale date as 02/23/2026 and indicates the transaction method as Cash Upon Exercise. The filing also records a prior sale of 1,168 ordinary shares on 01/07/2026.
Opaleye Management Inc., a more than ten percent owner of Sol-Gel Technologies Ltd., reported an indirect open-market purchase of 291 ordinary shares of Sol-Gel on February 13, 2026 at a price of $63.00 per share, through Opaleye, L.P.
After this transaction, Opaleye, L.P. held 450,335 ordinary shares, and a separately managed account overseen by Opaleye held 10,000 ordinary shares. Opaleye Management Inc. disclaims beneficial ownership of these shares except to the extent of its pecuniary interest.
Sol-Gel Technologies Ltd. reported an amended insider filing for Opaleye Management Inc., a more than 10% holder. Through Opaleye, L.P., a related fund, there was an open-market purchase of 100 ordinary shares at a price of 58.0000 per share on 2026-02-02.
After this trade, Opaleye, L.P. held 450,044 shares, and a separately managed account associated with Opaleye held 10,000 shares, both reported as indirect ownership. The amendment states it corrects the previously reported beneficially owned share count due to a clerical error, and Opaleye Management Inc. disclaims beneficial ownership except to the extent of its pecuniary interest.
Sol-Gel Technologies Ltd. had an insider ownership update involving entities managed by Opaleye Management Inc. On February 2, 2026, Opaleye, L.P. purchased 100 ordinary shares of Sol-Gel at $58 per share, bringing its indirectly held position to 450,944 ordinary shares. A separately managed account overseen by Opaleye Management holds an additional 10,000 ordinary shares indirectly. Opaleye Management Inc. states that it may be deemed to beneficially own these securities but disclaims beneficial ownership beyond its pecuniary interest.
Opaleye Management Inc., a 10% owner of Sol-Gel Technologies Ltd., reported an indirect open‑market purchase of 100 ordinary shares on January 27, 2026 at $57.05 per share. These shares are held by Opaleye, L.P., bringing that fund’s reported holdings to 449,944 shares. A separately managed account associated with Opaleye holds an additional 10,000 shares. Opaleye Management Inc. states it may be deemed to beneficially own these securities through its roles with the fund and managed account, but disclaims beneficial ownership except to the extent of its pecuniary interest.
Opaleye Management Inc., a 10% owner of Sol-Gel Technologies Ltd. (SLGL), reported January open-market share purchases made through affiliated investment vehicles. On January 22, 2026, Opaleye, L.P. bought 2,173 ordinary shares at a weighted average price of $56.5681 per share, and on January 23, 2026 it bought another 1,151 shares at a weighted average price of $55.9809. After these transactions, 449,844 ordinary shares were held indirectly through Opaleye, L.P., and an additional 10,000 shares were held indirectly via a separately managed account. The filing notes that prices reflect weighted averages across multiple trades within disclosed price ranges and that Opaleye Management Inc. disclaims beneficial ownership beyond its pecuniary interest.
SLGL security holder Itzik Yosef filed a Form 144 notice to sell 713 ordinary shares. The planned sale is to be executed through Oppenheimer & Co. Inc. on or about 01/14/2026, with an aggregate market value of $44,876.22, and the shares are listed on Nasdaq. The filing states that 27,857,620 ordinary shares were outstanding.
The 713 shares were acquired on 08/02/2016 under an employee stock option plan from the issuer, with cash payment upon option exercise dated 01/15/2026. In the past three months, the same seller has reported sales of 398, 54 and 3 ordinary shares on 01/07/2026, 01/12/2026 and 01/13/2026, for gross proceeds of $19,974.27, $3,513.01 and $195.00, respectively.